Amanote Research
Register
Sign In
Modified T Cells Home to Brain Tumors
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2018-125
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
September 24, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
RNA-modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
CAR T Cells for Brain Tumors: Lessons Learned and Road Ahead
Immunological Reviews
Allergy
Immunology
T Cells and T Cell Tumors Efficiently Generate Antigen-Specific Cytotoxic T Cell Immunity When Modified With an NKT Ligand
OncoImmunology
Oncology
Allergy
Immunology
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Cancer Discovery
Oncology
Home Sweet Home: How Do Virus Specific T Cells Navigate to the Skin?
Journal of Clinical Investigation
Medicine
Engineering Toxin-Resistant Therapeutic Stem Cells to Treat Brain Tumors
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Targeting Mesothelin With Modified T Cells
Cancer Discovery
Oncology
Oncolytic Virus Expressing RANTES and IL-15 Enhances Function of CAR-modified T Cells in Solid Tumors
OncoImmunology
Oncology
Allergy
Immunology
Anti-Pd-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors by Gene-Modified T Cells
Clinical Cancer Research
Cancer Research
Oncology